REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/25/2026
Back to search
Official data from USPTO
MEDIGAIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
05/26/2026
Trademark type
Word
Nice classes
3
Filing date
09/14/2017
Registration date
05/25/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/25/2021
Last transaction
05/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/01/2021
First use in commerce
04/01/2021
Drawing code
4
Owner type
16
Owner location
EAGAN, MN, US
Examiner
NEVILLE, BRIAN
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CREATIVE LABORATORIES, LLC
Creative Laboratories, Inc.
Creative Labs, Inc.
Representatives
Peter J. Ims WESTMAN, CHAMPLIN & KOEHLER, P.A.
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
skin care productsskin moisturizersbody lotions
Publications
History of USPTO decisions and trademark events.
37 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/26/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/25/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/23/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/22/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/02/2021
IUAF
USE AMENDMENT FILED
04/01/2021
EISU
TEAS STATEMENT OF USE RECEIVED
04/01/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/26/2020
EX5G
SOU EXTENSION 5 GRANTED
09/25/2020
EXT5
SOU EXTENSION 5 FILED
09/21/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/21/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/07/2020
EX4G
SOU EXTENSION 4 GRANTED
04/03/2020
EXT4
SOU EXTENSION 4 FILED
04/03/2020
EEXT
SOU TEAS EXTENSION RECEIVED
04/03/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/04/2019
EX3G
SOU EXTENSION 3 GRANTED
10/02/2019
EXT3
SOU EXTENSION 3 FILED
10/02/2019
EEXT
SOU TEAS EXTENSION RECEIVED
10/02/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/30/2019
EX2G
SOU EXTENSION 2 GRANTED
03/28/2019
EXT2
SOU EXTENSION 2 FILED
03/28/2019
EEXT
SOU TEAS EXTENSION RECEIVED
03/28/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/19/2018
EX1G
SOU EXTENSION 1 GRANTED
10/18/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/10/2018
EXT1
SOU EXTENSION 1 FILED
10/01/2018
EEXT
SOU TEAS EXTENSION RECEIVED
10/01/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/03/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2018
PUBO
PUBLISHED FOR OPPOSITION
02/06/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/17/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/22/2017
DOCK
ASSIGNED TO EXAMINER
12/19/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/19/2017
NWAP
NEW APPLICATION ENTERED
09/18/2017
Continuous trademark protection
Get notified about every new filing that threatens MEDIGAIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.